+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Iodinated Contrast Media"

From
Contrast Media - Global Strategic Business Report - Product Thumbnail Image

Contrast Media - Global Strategic Business Report

  • Report
  • April 2024
  • 513 Pages
  • Global
From
Contrast Media Global Market Report 2024 - Product Thumbnail Image

Contrast Media Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
From
From
Global Contrast Agent Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Global Contrast Agent Market Forecasts from 2023 to 2028

  • Report
  • October 2023
  • 102 Pages
  • Global
From
From
From
From
  • 18 Results (Page 1 of 1)
Loading Indicator

Iodinated Contrast Media (ICM) is a type of contrast media used in medical imaging to enhance the visibility of organs, tissues, and vessels. It is typically administered intravenously, and is composed of iodine-based compounds that absorb X-rays and create a contrast between the area of interest and the surrounding tissue. ICM is used in a variety of medical imaging procedures, including computed tomography (CT), magnetic resonance imaging (MRI), and angiography. ICM is a critical component of medical imaging, as it allows for the accurate diagnosis of a variety of medical conditions. It is also used to monitor the progress of treatments, such as chemotherapy and radiation therapy. The ICM market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include Bayer, Bracco Imaging, Guerbet, GE Healthcare, Lantheus Medical Imaging, Mallinckrodt, and Siemens Healthineers. Show Less Read more